COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,804 Articles (22,527 medRxiv, 8,277 bioRxiv)

Most recent first Previous |  Page 1691: Articles 16901-16910  | Next

SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release
Junqueira, C., Crespo, A., Ranjbar, S., Ingber, J., Parry, B., David, S., de Lacerda, L. B., Lewandrowski, M., Clark, S. A., Ho, F., Vora, S., Leger, V., Beackes, C., Margolin, J., Russell, N., Gehrke, L., Das Adhikari, U., Henderson, L., Janssen, E., Kwon, D., Sander, C., Abraham, J., Filbin, M., Goldberg, M. B., Wu, H., Gautam, M., Bell, S., Goldfeld, A., Lieberman, J.
10.1101/2021.03.06.21252796 — Posted: 2021-03-08
Exploration of interethnic variation and repurposed drug efficacy in the treatment of SARS-CoV-2 Infection (COVID-19)
Almarzooq, A. A.
10.1101/2021.03.07.21253095 — Posted: 2021-03-08
COVID-19 vaccine response in pregnant and lactating women: a cohort study
Gray, K. J., Bordt, E. A., Atyeo, C., Deriso, E., Akinwunmi, B., Young, N., Medina Baez, A., Shook, L. L., Cvrk, D., James, K., De Guzman, R., Brigida, S., Diouf, K., Goldfarb, I., Bebell, L. M., Yonker, L. M., Fasano, A., Rabi, S. A., Elovitz, M. A., Alter, G., Edlow, A. G.
10.1101/2021.03.07.21253094 — Posted: 2021-03-08
Post discharge persistent symptoms after COVID-19 in rheumatic and musculoskeletal diseases
Leon, L., Perez-Sancristobal, I., Madrid, A., Lopez Pedraza, L., Colomer, J. I., Lerma, S., Lois, P., Mucientes, A., Rodriguez-Rodriguez, L., Abasolo, L., Fernandez-Gutierrez, B.
10.1101/2021.03.08.21253120 — Posted: 2021-03-08
COVID-19 vaccine hesitancy in care home staff: a survey of Liverpool care homes
Tulloch, J. S. P., Lawrenson, K., Gordon, A. L., Ghebrehewet, S., Ashton, M., Peddie, S., Parvulescu, P.
10.1101/2021.03.07.21252972 — Posted: 2021-03-08
Estimating the impact of reopening schools on the reproduction number of SARS-CoV-2 in England, using weekly contact survey data
Munday, J. D., Jarvis, C. I., Gimma, A., Wong, K. L., van Zandvoort, K., CMMID COVID-19 Working Group, , Funk, S., Edmunds, W. J.
10.1101/2021.03.06.21252964 — Posted: 2021-03-08
Low Dose Regimens of BNT162b2 mRNA Vaccine Exceed SARS-Cov-2 Correlate of Protection Estimates for Symptomatic Infection, in those 19-55 Years of Age
Jurgens, G.
10.1101/2021.03.06.21253058 — Posted: 2021-03-08
BNT162b2 COVID-19 mRNA vaccine elicits a rapid and synchronized antibody response in blood and milk of breastfeeding women
Rosenberg Friedman, M., Kigel, A., Bahar, Y., Yogev, Y., Dror, Y., lubetzky, R., Many, A., Wine, Y.
10.1101/2021.03.06.21252603 — Posted: 2021-03-08
Inflammatory but not respiratory symptoms associated with ongoing upper airway viral replication in outpatients with uncomplicated COVID-19
Jacobson, K. B., Purington, N., Parsonnet, J., Andrews, J. R., Balasubramanian, V., Bonilla, H., Edwards, K., Desai, M., Singh, U., Hedlin, H., Jagannathan, P.
10.1101/2021.03.05.21253011 — Posted: 2021-03-08
Long-term clinical, virological and immunological outcomes in patients hospitalized for COVID-19: antibody response predicts long COVID.
Garcia-Abellan, J., Padilla, S., Fernandez-Gonzalez, M., Garcia, J. A., Agullo, V., Andreo, M., Ruiz, S., Galiana, A., Gutierrez, F., Masia, M.
10.1101/2021.03.08.21253124 — Posted: 2021-03-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).